Post by Ultragenyx

Jane Cooper, senior vice president and regional head for Ultragenyx EMEA, joined an important discussion at the Rare Diseases Forum on EU policy, regulation and access pathways to enable orphan drug development, support early diagnosis, and accelerate First ever treatments for people living with rare disease. In The Parliament article she shared solutions on ways to remove barriers and support timely access to care for people living with rare diseases across Europe. Read more: https://lnkd.in/gSDQzXXg